Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancer

Background Accurate detection of anaplastic lymphoma kinase (ALK) rearrangement is the prerequisite for anti‐ALK therapy for the patient with non‐small cell lung cancer (NSCLC). Fusion‐induced asymmetric transcription assay (FIATA)‐based reverse transcription droplet digital PCR (RT‐ddPCR) was devel...

Full description

Bibliographic Details
Main Authors: Yuanyuan Liu, Shafei Wu, Xiaohua Shi, Linping Lu, Lingxiang Zhu, Yong Guo, Li Zhang, Xuan Zeng
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Thoracic Cancer
Subjects:
ALK
Online Access:https://doi.org/10.1111/1759-7714.13535
id doaj-187976fc47744a4daee42f0ac53d0199
record_format Article
spelling doaj-187976fc47744a4daee42f0ac53d01992020-11-25T01:56:07ZengWileyThoracic Cancer1759-77061759-77142020-08-011182252226110.1111/1759-7714.13535Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancerYuanyuan Liu0Shafei Wu1Xiaohua Shi2Linping Lu3Lingxiang Zhu4Yong Guo5Li Zhang6Xuan Zeng7Department of Pathology Peking Union Medical College Hospital, Molecular Pathology Research Center, Chinese Academy of Medical Sciences Beijing ChinaDepartment of Pathology Peking Union Medical College Hospital, Molecular Pathology Research Center, Chinese Academy of Medical Sciences Beijing ChinaDepartment of Pathology Peking Union Medical College Hospital, Molecular Pathology Research Center, Chinese Academy of Medical Sciences Beijing ChinaTargetingOne Corporation Beijing ChinaNational Research Institute for Family Planning Beijing ChinaDepartment of Biomedical Engineering School of Medicine, Tsinghua University Beijing ChinaDepartment of Respiratory Diseases Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing ChinaDepartment of Pathology Peking Union Medical College Hospital, Molecular Pathology Research Center, Chinese Academy of Medical Sciences Beijing ChinaBackground Accurate detection of anaplastic lymphoma kinase (ALK) rearrangement is the prerequisite for anti‐ALK therapy for the patient with non‐small cell lung cancer (NSCLC). Fusion‐induced asymmetric transcription assay (FIATA)‐based reverse transcription droplet digital PCR (RT‐ddPCR) was developed and performed for ALK status survey in NSCLC samples. Methods A total of 269 cases of formalin‐fixed paraffin‐embedded (FFPE) specimens from NSCLC, in which ALK status was confirmed by both fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), were analyzed by FIATA‐based RT‐ddPCR. Results In the ALK‐positive group, the 3′ ALK transcript copies range was 336.6–107 955.4, and the R3 [(the ratio of the 3′ ALK transcript copy numbers to the internal reference gene transcript copy numbers) × 100] was 17.23–672.77. In the ALK‐negative group, the 3′ ALK transcript copies range was 3.7–1370.6, and the R3 range was 0.10–15.57. The lowest R3 level in the ALK‐positive group was significantly higher than the highest R3 level in the ALK‐negative group. A positive correlation between the proportion of cancer cells in the tissue section and ALK RNA expression level (R3) was found (P < 0.05). There was no relationship between the percentage of FISH positive cells or FISH positive signal patterns and R3 level of the ALK gene. Compared with FISH and IHC, the clinical sensitivity and specificity of FIATA‐based RT‐ddPCR for ALK detection were 100%, respectively. Conclusions An absolute quantitative FIATA‐based RT‐ddPCR was developed and validated for ALK fusion detection in NSCLC. This method can rapidly, accurately, and objectively classify ALK types and help with individual therapy.https://doi.org/10.1111/1759-7714.13535ALKasymmetricdroplet digital PCRlung cancerrearrangement
collection DOAJ
language English
format Article
sources DOAJ
author Yuanyuan Liu
Shafei Wu
Xiaohua Shi
Linping Lu
Lingxiang Zhu
Yong Guo
Li Zhang
Xuan Zeng
spellingShingle Yuanyuan Liu
Shafei Wu
Xiaohua Shi
Linping Lu
Lingxiang Zhu
Yong Guo
Li Zhang
Xuan Zeng
Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancer
Thoracic Cancer
ALK
asymmetric
droplet digital PCR
lung cancer
rearrangement
author_facet Yuanyuan Liu
Shafei Wu
Xiaohua Shi
Linping Lu
Lingxiang Zhu
Yong Guo
Li Zhang
Xuan Zeng
author_sort Yuanyuan Liu
title Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancer
title_short Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancer
title_full Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancer
title_fullStr Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancer
title_full_unstemmed Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR for ALK detection in formalin‐fixed paraffin‐embedded samples from lung cancer
title_sort clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital pcr for alk detection in formalin‐fixed paraffin‐embedded samples from lung cancer
publisher Wiley
series Thoracic Cancer
issn 1759-7706
1759-7714
publishDate 2020-08-01
description Background Accurate detection of anaplastic lymphoma kinase (ALK) rearrangement is the prerequisite for anti‐ALK therapy for the patient with non‐small cell lung cancer (NSCLC). Fusion‐induced asymmetric transcription assay (FIATA)‐based reverse transcription droplet digital PCR (RT‐ddPCR) was developed and performed for ALK status survey in NSCLC samples. Methods A total of 269 cases of formalin‐fixed paraffin‐embedded (FFPE) specimens from NSCLC, in which ALK status was confirmed by both fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), were analyzed by FIATA‐based RT‐ddPCR. Results In the ALK‐positive group, the 3′ ALK transcript copies range was 336.6–107 955.4, and the R3 [(the ratio of the 3′ ALK transcript copy numbers to the internal reference gene transcript copy numbers) × 100] was 17.23–672.77. In the ALK‐negative group, the 3′ ALK transcript copies range was 3.7–1370.6, and the R3 range was 0.10–15.57. The lowest R3 level in the ALK‐positive group was significantly higher than the highest R3 level in the ALK‐negative group. A positive correlation between the proportion of cancer cells in the tissue section and ALK RNA expression level (R3) was found (P < 0.05). There was no relationship between the percentage of FISH positive cells or FISH positive signal patterns and R3 level of the ALK gene. Compared with FISH and IHC, the clinical sensitivity and specificity of FIATA‐based RT‐ddPCR for ALK detection were 100%, respectively. Conclusions An absolute quantitative FIATA‐based RT‐ddPCR was developed and validated for ALK fusion detection in NSCLC. This method can rapidly, accurately, and objectively classify ALK types and help with individual therapy.
topic ALK
asymmetric
droplet digital PCR
lung cancer
rearrangement
url https://doi.org/10.1111/1759-7714.13535
work_keys_str_mv AT yuanyuanliu clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
AT shafeiwu clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
AT xiaohuashi clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
AT linpinglu clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
AT lingxiangzhu clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
AT yongguo clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
AT lizhang clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
AT xuanzeng clinicalevaluationoftheeffectivenessoffusioninducedasymmetrictranscriptionassaybasedreversetranscriptiondropletdigitalpcrforalkdetectioninformalinfixedparaffinembeddedsamplesfromlungcancer
_version_ 1724981437363388416